Trade Uncertainty Rattles Global Stock Markets | Open Interest 2/23/2026
Speakers
Summary
- Macro Regime Shift: The Supreme Court struck down the President's use of IEEPA for tariffs, prompting the Administration to pivot to Section 122 (15% tariffs for 150 days). This has created a "purple haze of policy uncertainty," causing the EU to freeze trade deal ratification.
- Tariff Reality Check: Despite the legal setback for the Administration, Rep. Jason Smith confirms there is "no pathway" for corporate tariff refunds, dashing hopes for a liquidity injection into importers.
- Pharma Divergence: A major regime shift in the obesity market occurred as Novo Nordisk's next-gen drug underperformed Eli Lilly's in a head-to-head trial, signaling a potential moat breach for Novo.
- Private Market Stress: Private Credit is showing cracks, specifically with Blue Owl facing redemption pressure, marking the worst dry spell for Private Equity since 2008.
- Commodities Resilience: Despite trade chaos, Copper remains insulated due to Section 232 stability and secular demand from AI data centers.
Trade Ideas
Novo Nordisk's (NVO) next-gen obesity shot (CagriSema) showed 20% weight loss compared to 23% for Eli Lilly's (LLY) drug in a head-to-head trial. NVO stock plunged 15.3% while LLY surged 3.5%. The obesity duopoly is fracturing. Novo "rolled the dice" on a head-to-head comparison and lost, proving their next-gen pipeline is inferior to Lilly's. This erodes Novo's future growth premium (30% of future revenue was tied to this) and cements Lilly as the clinical leader. LONG LLY (Best in Class) / SHORT NVO (Broken Growth Thesis). Regulatory intervention on drug pricing or unexpected side effects in Lilly's broader rollout.
The DOJ is investigating the Netflix (NFLX) merger with Warner Bros (WBD) for anticompetitive behavior (Sherman Act), and President Trump posted on Truth Social demanding the firing of a Netflix board member. The deal faces dual headwinds: aggressive antitrust enforcement and direct political targeting from the White House. This introduces significant "deal break" risk and headline volatility. WATCH NFLX / WBD (Binary outcome based on regulatory/political news flow). Deal is approved with minor concessions, causing a relief rally.
Blue Owl (OWL) is selling assets to meet redemptions in a $1.6B fund, rattling the $1.8T private credit market. Bain reports the worst dry spell for PE since 2008. The "liquidity mismatch" in private credit is being tested. Retail investors (wealth channel) are panicking, forcing fire sales of assets. When a major player like Blue Owl faces redemption stress, it signals systemic liquidity risks in the asset class. AVOID OWL and PRIVATE CREDIT / SPECIALTY FINANCE. Fed cuts rates aggressively, easing liquidity pressure.
Freeport-McMoRan CEO states that the recent Supreme Court ruling on IEEPA does not impact Copper, as it falls under Section 232 tariffs which remain intact. While the broader market panics over trade war uncertainty, Copper's fundamentals are driven by secular trends (AI data centers, electrification) and supply constraints. The CEO confirmed they are not stockpiling but selling through to meet intense demand. LONG FCX (Insulated from current tariff chaos + AI infrastructure play). Global recession crushing industrial demand.
Alex Chaloff
Chief Investment Officer, Bernstein Private Wealth
Chaloff predicts "No US [equities] will do well" in 2026 due to valuation concerns and policy chaos, while stating "Non-US markets will do quite well." The US market is pricing in perfection despite "chaos" and tariff uncertainty. International markets (Europe/Japan) offer better valuations and are benefiting from a weaker dollar tailwind. The trade is a rotation out of expensive US beta into cheaper global beta. LONG NON-US EQUITIES (Valuation/Currency Play). Global trade war escalates (15% tariffs), hurting export-heavy international economies more than the US.
Tom Donnelly
CEO, Mazda North America
Mazda CEO confirms the new 15% tariffs impact their operations. While they are ramping US production (Alabama), key models like the Mazda 3 are imported and face immediate cost hikes. Automakers are in the crosshairs of the new Section 122 tariffs. They face a choice: absorb the 15% cost (crushing margins) or pass it to consumers (crushing demand). With affordability already an issue, this sector faces a "lose-lose" policy environment. AVOID AUTO SECTOR. Administration grants specific exemptions for auto imports from allies.
Dani Burger
Anchor, Bloomberg Television
Domino's (DPZ) sales topped estimates as "budget-friendly prices lured consumers." The consumer is trading down. In an environment of economic uncertainty and inflation (tariffs), low-cost food options capture market share from casual dining. DPZ is the classic "trade-down" beneficiary. LONG DPZ (Defensive Consumer Staple behavior). Input cost inflation (cheese/dough) squeezing margins.
Up Next
This Bloomberg Markets video, published February 23, 2026, features Sam Fazeli, Ed Ludlow, Allison McNealy, Kathleen Quirk, Alex Chaloff, Tom Donnelly, Dani Burger discussing LLY, NVO, NFLX, WBD, OWL, BKLN, FCX, EFA, CARZ, DPZ. 7 trade ideas extracted by AI with direction and confidence scoring.
Speakers: Sam Fazeli, Ed Ludlow, Allison McNealy, Kathleen Quirk, Alex Chaloff, Tom Donnelly, Dani Burger · Tickers: LLY, NVO, NFLX, WBD, OWL, BKLN, FCX, EFA, CARZ, DPZ